Segment Information

12 Months Ended

Dec. 31, 2013

Segment Reporting, Measurement Disclosures [Abstract]

Segment Information

SEGMENT INFORMATION

The Company operates and reports its results in five separate business segments consisting of the Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial Technologies segments. In addition, the Company’s equity in earnings of the Apex joint venture is shown separately in the Company’s segment disclosures. Operating profit represents total revenues less operating expenses, excluding other expense, interest and income taxes. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.

Detailed segment data for the years ended December 31, 2013, 2012 and 2011 is presented in the following table ($ in millions):

	2013			2012			2011
Total sales:
Test & Measurement	$	3,417.3		$	3,381.0		$	3,390.9
Environmental	3,316.9			3,063.5			2,939.6
Life Sciences & Diagnostics	6,856.4			6,485.1			4,627.4
Dental	2,094.9			2,022.9			2,011.2
Industrial Technologies	3,432.5			3,307.9			3,121.4
Total	$	19,118.0		$	18,260.4		$	16,090.5
Operating profit:
Test & Measurement	$	669.5		$	701.2		$	751.2
Environmental	696.5			652.5			622.7
Life Sciences & Diagnostics	1,009.8			861.1			402.3
Dental	304.9			293.1			236.1
Industrial Technologies	722.9			685.6			655.0
Equity method earnings related to Apex joint venture	—			69.9			66.8
Other	(128.7		)	(98.3		)	(116.9		)
Total	$	3,274.9		$	3,165.1		$	2,617.2
Identifiable assets (including assets held for sale):
Test & Measurement	$	5,495.0		$	5,505.8		$	5,280.6
Environmental	3,584.5			3,146.6			2,784.8
Life Sciences & Diagnostics	13,614.7			13,305.2			12,888.4
Dental	4,095.1			4,079.9			4,047.5
Industrial Technologies	4,363.6			4,235.6			3,394.9
Other	3,519.3			2,667.9			1,553.3
Total	$	34,672.2		$	32,941.0		$	29,949.5
Depreciation and amortization:
Test & Measurement	$	135.1		$	132.3		$	126.6
Environmental	62.7			48.9			45.9
Life Sciences & Diagnostics	517.3			478.2			297.2
Dental	83.3			92.4			94.0
Industrial Technologies	89.2			80.8			65.8
Other	7.4			7.2			5.5
Total	$	895.0		$	839.8		$	635.0

	2013		2012		2011
Capital expenditures, gross:
Test & Measurement	$	38.8	$	37.5	$	37.7
Environmental	46.5		29.5		29.1
Life Sciences & Diagnostics	386.7		296.8		167.0
Dental	30.7		30.2		35.4
Industrial Technologies	47.1		49.0		51.3
Other	1.7		15.3		14.0
Total	$	551.5	$	458.3	$	334.5

Operations in Geographical Areas

Year Ended December 31

($ in millions)	2013		2012		2011
Sales:
United States	$	8,109.3	$	7,809.8	$	6,787.8
China	1,631.8		1,443.5		1,133.2
Germany	1,182.8		1,111.3		1,189.0
Japan	777.7		892.8		809.4
All other (each country individually less than 5% of total sales)	7,416.4		7,003.0		6,171.1
Total	$	19,118.0	$	18,260.4	$	16,090.5
Long-lived assets (including assets held for sale):
United States	$	15,673.7	$	15,980.8	$	16,433.0
Germany	1,939.7		1,957.1		1,455.8
All other (each country individually less than 5% of total long-lived assets)	7,945.1		7,415.3		5,788.3
Total	$	25,558.5	$	25,353.2	$	23,677.1

Sales by Major Product Group

Year Ended December 31

($ in millions)	2013		2012		2011
Analytical & physical instrumentation	$	6,278.5	$	6,000.8	$	5,920.9
Medical & dental products	8,958.0		8,509.1		6,653.5
Motion & industrial automation controls	1,559.1		1,592.4		1,677.1
Product identification	1,551.5		1,410.3		1,162.1
All other	770.9		747.8		676.9
Total	$	19,118.0	$	18,260.4	$	16,090.5